These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9602182)

  • 21. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak.
    Lapointe JY; Tessier J; Paquette Y; Wallendorff B; Coady MJ; Pichette V; Bonnardeaux A
    Kidney Int; 2006 Jun; 69(12):2261-7. PubMed ID: 16688119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease.
    Igarashi T; Inatomi J; Ohara T; Kuwahara T; Shimadzu M; Thakker RV
    Kidney Int; 2000 Aug; 58(2):520-7. PubMed ID: 10916075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies.
    Scheinman SJ; Pook MA; Wooding C; Pang JT; Frymoyer PA; Thakker RV
    J Clin Invest; 1993 Jun; 91(6):2351-7. PubMed ID: 8099916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent hypercalciuric nephrolithiasis--does diet help?
    Bushinsky DA
    N Engl J Med; 2002 Jan; 346(2):124-5. PubMed ID: 11784880
    [No Abstract]   [Full Text] [Related]  

  • 25. Hereditary aspects of calcium nephrolithiasis.
    Coe FL; Parks JH
    Adv Nephrol Necker Hosp; 1991; 20():31-40. PubMed ID: 2063720
    [No Abstract]   [Full Text] [Related]  

  • 26. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and calcium nephrolithiasis.
    Vezzoli G; Terranegra A; Arcidiacono T; Soldati L
    Kidney Int; 2011 Sep; 80(6):587-93. PubMed ID: 20962745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrolithiasis.
    Scheinman SJ
    Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets.
    Kelleher CL; Buckalew VM; Frederickson ED; Rhodes DJ; Conner DA; Seidman JG; Seidman CE
    Kidney Int; 1998 Jan; 53(1):31-7. PubMed ID: 9452997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis.
    Hoopes RR; Hueber PA; Reid RJ; Braden GL; Goodyer PR; Melnyk AR; Midgley JP; Moel DI; Neu AM; VanWhy SK; Scheinman SJ
    Kidney Int; 1998 Sep; 54(3):698-705. PubMed ID: 9734595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones.
    Vezzoli G; Soldati L; Proverbio MC; Adamo D; Rubinacci A; Bianchi G; Mora S
    J Nephrol; 2002; 15(2):158-64. PubMed ID: 12018632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dent disease with compound heterozygous mutations leading to severe chronic renal failure in a female patient.
    Holder M; Bald M; Leichter HE; Ludwig M
    Pediatr Nephrol; 2004 Jan; 19(1):122; author reply 123. PubMed ID: 14648329
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetes and nephrolithiasis in a patient with a long arm X-isochromosome.
    Jiménez M; Sánchez F; Forsbach G; Orozco A; Zárate A; Canales ES
    Rev Invest Clin; 1976; 28(3):263-5. PubMed ID: 830096
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of hypophosphatemia in calcium nephrolithiasis.
    Yamakawa K; Kawamura J
    Mol Urol; 2000; 4(4):365-70. PubMed ID: 11156704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Laplante K; Asplin JR
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Normocalcemic nephrolithiasis and primary hyperparathyroidism].
    Buser U; Lauffenburger T; Wacker HR; Hagmaier V; Rutishauser G; Haas HG
    Helv Chir Acta; 1978 Jul; 45(3):263-6. PubMed ID: 701062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metolazone therapy of active calcium nephrolithiasis.
    Cunningham E; Oliveros FH; Nascimento L
    Clin Pharmacol Ther; 1982 Nov; 32(5):642-5. PubMed ID: 7128005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does crystal deposition in genetic hypercalciuric rat kidney tissue share similarities with bone formation?
    Jia Z; Wang S; Tang J; He D; Cui L; Liu Z; Guo B; Huang L; Lu Y; Hu H
    Urology; 2014 Feb; 83(2):509.e7-14. PubMed ID: 24468523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis.
    Matsushita K; Tanikawa K
    Tokai J Exp Clin Med; 1987 Sep; 12(3):167-71. PubMed ID: 3454077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage.
    Wolf MT; Zalewski I; Martin FC; Ruf R; Müller D; Hennies HC; Schwarz S; Panther F; Attanasio M; Acosta HG; Imm A; Lucke B; Utsch B; Otto E; Nurnberg P; Nieto VG; Hildebrandt F
    Nephrol Dial Transplant; 2005 May; 20(5):909-14. PubMed ID: 15741201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.